Lansoprazole vs Tofacitinib

## Lansoprazole vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Lansoprazole** and **Tofacitinib**.

## Mechanism of Action

**Lansoprazole**: Proton pump inhibitor.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Lansoprazole — 1.5 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Lansoprazole — C16H14F3N3O2S; Tofacitinib — C16H20N6O.

**Molecular Weight**: Lansoprazole — 369.3620 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Lansoprazole — Small molecule; Tofacitinib — Small molecule.